Leishmanicidal Activity of Biogenic Fe₃O₄ Nanoparticles

Due to the multiplicity of useful applications of metal oxide nanoparticles (ONPs) in medicine are growing exponentially, in this study, Fe₃O₄ (iron oxide) nanoparticles (IONPs) were biosynthesized using Rosemary to evaluate the leishmanicidal efficiency of green synthesized IONPs. This is the first...

Full description

Saved in:
Bibliographic Details
Published inScientia pharmaceutica Vol. 85; no. 4; p. 36
Main Authors Khatami, Mehrdad, Alijani, Hajar, Sharifi, Iraj, Sharifi, Fatemeh, Pourseyedi, Shahram, Kharazi, Sam, Lima Nobre, Marcos Augusto, Khatami, Manouchehr
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 20.11.2017
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Due to the multiplicity of useful applications of metal oxide nanoparticles (ONPs) in medicine are growing exponentially, in this study, Fe₃O₄ (iron oxide) nanoparticles (IONPs) were biosynthesized using Rosemary to evaluate the leishmanicidal efficiency of green synthesized IONPs. This is the first report of the leishmanicidal efficiency of green synthesized IONPs against The resulting biosynthesized IONPs were characterized by ultraviolet-visible spectroscopy (UV-Vis), X-ray diffraction (XRD), transmission electron microscopy (TEM), and Fourier transform infrared spectroscopy (FTIR). The leishmanicidal activity of IONPS was studied via 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The results showed the fabrication of the spherical shape of monodisperse IONPs with a size 4 ± 2 nm. The UV-visible spectrophotometer absorption peak was at 334 nm. The leishmanicidal activity of biogenic iron oxide nanoparticles against (promastigote) was also studied. The IC of IONPs was 350 µg/mL. In this report, IONPs were synthesized via a green method. IONPs are mainly spherical and homogeneous, with an average size of about 4 nm, and were synthesized here using an eco-friendly, simple, and inexpensive method.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2218-0532
0036-8709
2218-0532
DOI:10.3390/scipharm85040036